Skip to main content

Table 6 People at risk of gambiense HAT that are potentially covered by facilities with different types of treatment capabilities for HAT

From: Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis

Type of treatment At-risk population potentially covered [%]
  ≤ 1 hour travel time ≤ 3 hour travel time ≤ 5 hour travel time
  VH-H M L-VL VH-H M L-VL VH-H M L-VL
Tx1P 47 39 36 76 71 66 87 83 80
Tx2M 38 34 27 70 66 62 84 81 76
Tx2E 38 33 32 70 66 59 84 80 72
Tx2N 31 30 26 62 63 52 74 77 64
  1. Tx1P: treatment of first-stage infection with pentamidine; Tx2M: treatment of second-stage infection with melarsoprol; Tx2E: treatment of second-stage infection with eflornithine; Tx2N: treatment of second-stage infection with nifurtimox-eflornithine combination therapy (NECT). VH: Very high risk; H: High risk; M: Moderate risk; L: Low risk; VL: Very low risk. People at risk are stratified by risk categories as defined in[7].